Skip to main content
ADVANCED SEARCH
Log in
Top

Current Treatment Options in Neurology

Issue 9/2024

Content (2 Articles)

Efficacy and Safety of Atogepant for Preventing Chronic and Episodic Migraines: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Lucca Moreira Lopes, Artur Menegaz de Almeida, Eric Pasqualotto, Renan Yuji Ura Sudo, Marianna Gerardo Hidalgo Santos Jorge Leite, Maria Eduarda Cavalcanti Souza, Francisco Cezar Aquino de Moraes, Victória Morbach Siebel, Nathália Figueiredo

TINNITUS. A Non-invasive Neuromodulatory Perspective

Simone Rossi, Marco Mandalà

Aug 24
Issue: 8/2024
Oct 24
Issue: 10/2024

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

How can your team use biomarkers to improve management of AD? (Link opens in a new window)

Our experts explore using biomarker tests and interpreting results, establishing a shared decision-making approach with patients and caregivers, and applying biomarker testing to guide treatment strategies.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Register your interest

How can you integrate PET into your practice? (Link opens in a new window)

1.5 AMA PRA Category 1 Credit(s)™

PET imaging is playing an increasingly critical role in managing AD. Our expert-led program will empower you with practical strategies and real-world case studies to effectively integrate it into clinical practice.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Register your interest
Image Credits